Herbert, Carly
Shi, Qiming
Baek, Jonggyu
Wang, Biqi
Kheterpal, Vik
Nowak, Christopher
Suvarna, Thejas
Singh, Aditi
Hartin, Paul
Durnam, Basyl
Schrader, Summer
Harman, Emma
Gerber, Ben
Barton, Bruce
Zai, Adrian
Cohen-Wolkowiez, Michael
Corbie-Smith, Giselle
Kibbe, Warren
Marquez, Juan
Hafer, Nathaniel
Broach, John
Lin, Honghuang
Heetderks, William
McManus, David D
Soni, Apurv
Funding for this research was provided by:
Center for Clinical and Translational Science, University of Massachusetts (UL1-TR001453)
National Institutes of Health (UL1TR001453, 3U54HL143541-02S2, 3U54HL143541-02S2, 3U54HL143541-02S2, 3U54HL143541-02S2)
Article History
Received: 24 April 2023
Accepted: 29 August 2023
First Online: 22 September 2023
Declarations
:
: The University of Massachusetts Institutional Review Board determined this study was exempt from IRB review and informed consent was waived because this secondary analysis uses data where subjects cannot be identified directly or through identifiers. All methods were performed according to the Declaration of Helsinki.
: Not applicable.
: VK is principal, and TS, SS, CN, and EH are employees of health care technology company CareEvolution. DDM reports consulting and research grants from Bristol-Myers Squibb and Pfizer, consulting and research support from Fitbit, consulting, and research support from Flexcon, research grant from Boehringer Ingelheim, consulting from Avania, non-financial research support from Apple Computer, consulting/other support from Heart Rhythm Society. All other authors declare no competing interests.